FDA has approved a SC autoinjector of Benlysta (BEL) for use in pediatric lupus nephritis & pts > 5rs of age for SLE and active LN. BEL SC dosing for Pediatric SLE: 200 mg qwk (>40 kg) or 200 mg EOW (q2wk) if 15-40 kg. https://t.co/zrskHdw9Jx https://t.co/jkqygmfJPv
Links:
FDA Approves Belimumab (Benlysta) Autoinjector for Pediatric Lupus Nephritis
https://buff.ly/5yxk5HA
Jun-30-2025
